Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Nitsch

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Cerebral Cortex (New York, N.Y. : 1991)|November 2, 2006
Better memory and neural efficiency in young apolipoprotein E epsilon4 carriersChristian R A Mondadori, Dominique J-F de Quervain, Andreas Buchmann, et al.
Neurochemical Research|December 31, 2008
Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- miceKatrin Kuehnle, Maria D Ledesma, Lucie Kalvodova, et al.
Frontiers in Aging Neuroscience|March 27, 2020
Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4Frances C Quevenco, Jiri M van Bergen, Valerie Treyer, et al.
Translational Neurodegeneration|September 24, 2025
Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer's disease: associations with Aβ, tau, synaptic proteins and APOE ε4Jana Nussbaumer, Aatmika Barve, Valentin Zufferey, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2003
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's diseaseChristoph Hock, Alessia Maddalena, Andreas Raschig, et al.
Frontiers in Aging Neuroscience|March 28, 2014
Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar SystemStefanie C Steininger, Xinyang Liu, Anton Gietl, et al.
Neuroreport|May 14, 2005
Age-dependent effects of the 5-hydroxytryptamine-2a-receptor polymorphism (His452Tyr) on human memoryAndreas Papassotiropoulos, Katharina Henke, Amanda Aerni, et al.
Science Translational Medicine|December 7, 2018
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosisMarcel Maier, Tobias Welt, Fabian Wirth, et al.
Brain : a Journal of Neurology|April 3, 2010
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathologyAlberto Serrano-Pozo, Christopher M William, Isidro Ferrer, et al.
Brain : a Journal of Neurology|May 5, 2025
Altered T-cell reactivity in the early stages of Alzheimer's diseaseChiara Rickenbach, Anna Mallone, Lars Häusle, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Cerebral Cortex (New York, N.Y. : 1991)|November 2, 2006
Better memory and neural efficiency in young apolipoprotein E epsilon4 carriersChristian R A Mondadori, Dominique J-F de Quervain, Andreas Buchmann, et al.
Neurochemical Research|December 31, 2008
Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- miceKatrin Kuehnle, Maria D Ledesma, Lucie Kalvodova, et al.
Frontiers in Aging Neuroscience|March 27, 2020
Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4Frances C Quevenco, Jiri M van Bergen, Valerie Treyer, et al.
Translational Neurodegeneration|September 24, 2025
Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer's disease: associations with Aβ, tau, synaptic proteins and APOE ε4Jana Nussbaumer, Aatmika Barve, Valentin Zufferey, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2003
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's diseaseChristoph Hock, Alessia Maddalena, Andreas Raschig, et al.
Frontiers in Aging Neuroscience|March 28, 2014
Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar SystemStefanie C Steininger, Xinyang Liu, Anton Gietl, et al.
Neuroreport|May 14, 2005
Age-dependent effects of the 5-hydroxytryptamine-2a-receptor polymorphism (His452Tyr) on human memoryAndreas Papassotiropoulos, Katharina Henke, Amanda Aerni, et al.
Science Translational Medicine|December 7, 2018
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosisMarcel Maier, Tobias Welt, Fabian Wirth, et al.
Brain : a Journal of Neurology|April 3, 2010
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathologyAlberto Serrano-Pozo, Christopher M William, Isidro Ferrer, et al.
Brain : a Journal of Neurology|May 5, 2025
Altered T-cell reactivity in the early stages of Alzheimer's diseaseChiara Rickenbach, Anna Mallone, Lars Häusle, et al.
Pageof 17